ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,148, issued on Oct. 20, was assigned to Biomed Valley Discoveries Inc. (Kansas City, Mo.).
"Cancer treatments using combinations of CDK and ERK inhibitors" was invented by Saurabh Saha (Wellesley Hills, Mass.), Dean Welsch (Parkville, Mo.), Gary DeCrescenzo (Parkville, Mo.) and Jeffrey James Roix (Boston).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides, inter alia, methods, kits, and pharmaceutical compositions for treating or ameliorating the effects of a cancer in a subject in need thereof. The method comprises administering to the subject an effective amount of (i) a first anti-cancer agent, which is BVD-523 or a phar...